Combination Therapy (Provigil + Avonex) to Treat Cognitive Problems in MS

Summary

MS has been associated with fatigue, attention problems, and a number of cognitive difficulties. There is no treatment approved yet to treat these problems. We hypothesize that the addition of Provigil to an existing immunomodulatory agent (Avonex) will lead to improved fatigue, attention, and overall cognition in MS patients with attention problems.

Timeline

Start

2003-01

Primary completion

—

Completion

—

Drugs

Indications